CliniExperts Supports Completion of AMPLIFY-TIR Diabetes Study

New Delhi [India], March 18: We are pleased to announce the successful completion of the AMPLIFY-TIR Study, which...

Kidney stone risk is lowered by a class of diabetes medications

Researchers at Mass General Brigham discovered that using sodium-glucose contratransporter 2 (SGLT2) inhibitors was...

Sotagliflozin provides kidney, heart-related benefits to patients

Patients with and without diabetes can benefit from sodium-glucose cotransporter-2 (SGLT2) inhibitors, which are...

Daewoong Pharmaceutical has obtained approval for drug Envlomet

Seoul [South Korea], July 19: Daewoong Pharmaceutical obtained approval for a SGLT-2 inhibitor+metformin combination...

Study challenges previous link between diabetes meds and fracture

Washington [US], May 27 (ANI): Sodium-glucose transporter-2 (SGLT2) inhibitors, which reduce renal glucose...

Glenmark becomes the first company to launch Remogliflozin +...

Mumbai (Maharashtra) [India], October 26 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark), a...

Glenmark Pharmaceuticals launches fixed-drug combination for...

Mumbai (Maharashtra) [India], October 26 (ANI): Glenmark Pharmaceuticals Limited (Glenmark), a research-led...

Glenmark becomes the first company to launch Remogliflozin +...

Mumbai (Maharashtra) [India], December 29 . (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark), a...

Newer Type 2 diabetes medications have heart and kidney...

Washington [US], September 28 (ANI): Two newer groups of medications prescribed primarily for Type 2 diabetes...